Cargando…

Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli

BACKGROUND: Methylated resveratrol analogs show similar biological activities that are comparable with those of the resveratrol. However, the methylated resveratrol analogs exhibit better bioavailability as they are more easily transported into the cell and more resistant to degradation. Although th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Sun-Young, Lee, Jae Kyoung, Choi, Oksik, Kim, Cha Young, Jang, Jae-Hyuk, Hwang, Bang Yeon, Hong, Young-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118633/
https://www.ncbi.nlm.nih.gov/pubmed/25033820
http://dx.doi.org/10.1186/1472-6750-14-67
_version_ 1782328872745828352
author Kang, Sun-Young
Lee, Jae Kyoung
Choi, Oksik
Kim, Cha Young
Jang, Jae-Hyuk
Hwang, Bang Yeon
Hong, Young-Soo
author_facet Kang, Sun-Young
Lee, Jae Kyoung
Choi, Oksik
Kim, Cha Young
Jang, Jae-Hyuk
Hwang, Bang Yeon
Hong, Young-Soo
author_sort Kang, Sun-Young
collection PubMed
description BACKGROUND: Methylated resveratrol analogs show similar biological activities that are comparable with those of the resveratrol. However, the methylated resveratrol analogs exhibit better bioavailability as they are more easily transported into the cell and more resistant to degradation. Although these compounds are widely used in human health care and in industrial materials, at present they are mainly obtained by extraction from raw plant sources. Accordingly their production can suffer from a variety of economic problems, including low levels of productivity and/or heterogeneous quality. On this backdrop, large-scale production of plant metabolites via microbial approaches is a promising alternative to chemical synthesis and extraction from plant sources. RESULTS: An Escherichia coli system containing an artificial biosynthetic pathway that produces methylated resveratrol analogues, such as pinostilbene (3,4’-dihydroxy-5-methoxystilbene), 3,5-dihydroxy-4’-methoxystilbene, 3,4’-dimethoxy-5-hydroxystilbene, and 3,5,4’-trimethoxystilbene, from simple carbon sources is developed. These artificial biosynthetic pathways contain a series of codon-optimized O-methyltransferase genes from sorghum in addition to the resveratrol biosynthetic genes. The E. coli cells that harbor pET-opTLO1S or pET-opTLO3S produce the one-methyl resveratrol analogues of 3,5-dihydroxy-4’-methoxystilbene and pinostilbene, respectively. Furthermore, the E. coli cells that harbor pET-opTLO13S produce 3,5-dihydroxy-4’-methoxystilbene, bis-methyl resveratrol (3,4’-dimethoxy-5-hydroxystilbene), and tri-methyl resveratrol (3,5,4’-trimethoxystilbene). CONCLUSIONS: Our strategy demonstrates the first harness microorganisms for de novo synthesis of methylated resveratrol analogs used a single vector system joined with resveratrol biosynthetic genes and sorghum two resveratrol O-methyltransferase genes. Thus, this is also the first report on the production of the methylated resveratrol compounds bis-methyl and tri-methyl resveratrol (3,4’-dimethoxy-5-hydroxystilbene and 3,5,4’-trimethoxystilbene) in the E. coli culture. Thus, the production of the methylated resveratrol compounds was performed on the simple E. coli medium without precursor feeding in the culture.
format Online
Article
Text
id pubmed-4118633
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41186332014-08-02 Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli Kang, Sun-Young Lee, Jae Kyoung Choi, Oksik Kim, Cha Young Jang, Jae-Hyuk Hwang, Bang Yeon Hong, Young-Soo BMC Biotechnol Research Article BACKGROUND: Methylated resveratrol analogs show similar biological activities that are comparable with those of the resveratrol. However, the methylated resveratrol analogs exhibit better bioavailability as they are more easily transported into the cell and more resistant to degradation. Although these compounds are widely used in human health care and in industrial materials, at present they are mainly obtained by extraction from raw plant sources. Accordingly their production can suffer from a variety of economic problems, including low levels of productivity and/or heterogeneous quality. On this backdrop, large-scale production of plant metabolites via microbial approaches is a promising alternative to chemical synthesis and extraction from plant sources. RESULTS: An Escherichia coli system containing an artificial biosynthetic pathway that produces methylated resveratrol analogues, such as pinostilbene (3,4’-dihydroxy-5-methoxystilbene), 3,5-dihydroxy-4’-methoxystilbene, 3,4’-dimethoxy-5-hydroxystilbene, and 3,5,4’-trimethoxystilbene, from simple carbon sources is developed. These artificial biosynthetic pathways contain a series of codon-optimized O-methyltransferase genes from sorghum in addition to the resveratrol biosynthetic genes. The E. coli cells that harbor pET-opTLO1S or pET-opTLO3S produce the one-methyl resveratrol analogues of 3,5-dihydroxy-4’-methoxystilbene and pinostilbene, respectively. Furthermore, the E. coli cells that harbor pET-opTLO13S produce 3,5-dihydroxy-4’-methoxystilbene, bis-methyl resveratrol (3,4’-dimethoxy-5-hydroxystilbene), and tri-methyl resveratrol (3,5,4’-trimethoxystilbene). CONCLUSIONS: Our strategy demonstrates the first harness microorganisms for de novo synthesis of methylated resveratrol analogs used a single vector system joined with resveratrol biosynthetic genes and sorghum two resveratrol O-methyltransferase genes. Thus, this is also the first report on the production of the methylated resveratrol compounds bis-methyl and tri-methyl resveratrol (3,4’-dimethoxy-5-hydroxystilbene and 3,5,4’-trimethoxystilbene) in the E. coli culture. Thus, the production of the methylated resveratrol compounds was performed on the simple E. coli medium without precursor feeding in the culture. BioMed Central 2014-07-17 /pmc/articles/PMC4118633/ /pubmed/25033820 http://dx.doi.org/10.1186/1472-6750-14-67 Text en Copyright © 2014 Kang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Kang, Sun-Young
Lee, Jae Kyoung
Choi, Oksik
Kim, Cha Young
Jang, Jae-Hyuk
Hwang, Bang Yeon
Hong, Young-Soo
Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli
title Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli
title_full Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli
title_fullStr Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli
title_full_unstemmed Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli
title_short Biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in E. coli
title_sort biosynthesis of methylated resveratrol analogs through the construction of an artificial biosynthetic pathway in e. coli
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118633/
https://www.ncbi.nlm.nih.gov/pubmed/25033820
http://dx.doi.org/10.1186/1472-6750-14-67
work_keys_str_mv AT kangsunyoung biosynthesisofmethylatedresveratrolanalogsthroughtheconstructionofanartificialbiosyntheticpathwayinecoli
AT leejaekyoung biosynthesisofmethylatedresveratrolanalogsthroughtheconstructionofanartificialbiosyntheticpathwayinecoli
AT choioksik biosynthesisofmethylatedresveratrolanalogsthroughtheconstructionofanartificialbiosyntheticpathwayinecoli
AT kimchayoung biosynthesisofmethylatedresveratrolanalogsthroughtheconstructionofanartificialbiosyntheticpathwayinecoli
AT jangjaehyuk biosynthesisofmethylatedresveratrolanalogsthroughtheconstructionofanartificialbiosyntheticpathwayinecoli
AT hwangbangyeon biosynthesisofmethylatedresveratrolanalogsthroughtheconstructionofanartificialbiosyntheticpathwayinecoli
AT hongyoungsoo biosynthesisofmethylatedresveratrolanalogsthroughtheconstructionofanartificialbiosyntheticpathwayinecoli